Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
New York State Psychiatric Institute
Age
18–55
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Age 18-55
Physically healthy and not currently pregnant
Primary Diagnosis of OCD
currently off all psychotropic medications and other drugs
Able to provide informed consent
Age 18-55
Physically healthy and not currently pregnant
Primary Diagnosis of OCD
Currently on adequate dose of medication for treatment of OCD, but have not achieved at least partial remission and able to handle a medication washout.
Able to provide informed consent
You may not be if
Psychiatric conditions that make participation unsafe (schizophrenia \[either self or first degree relative e.g. siblings, parents\], history of violence, severe depression, eating disorder, substance abuse in prior year\[including nicotine\], lifetime substance dependence disorder \[except nicotine\])
Female patients who are either pregnant or nursing
Enrolled in or planning to enroll in Cognitive Behavioral Therapy.
Medical conditions that make participation unsafe (e.g., high blood pressure, head injury)
Currently on medications that make participation unsafe
History of allergy, sensitivity, or intolerance to N-methyl-D-aspartate receptor (NMDAR) ligands including ketamine, dextromethorphan, memantine, methadone, dextropropoxyphene, or ketobemidone.
Psychiatric conditions that make participation unsafe (schizophrenia \[either self or first degree relative e.g. siblings, parents\], history of violence, severe depression, eating disorder, substance abuse in prior year\[including nicotine\], lifetime substance dependence disorder \[except nicotine\])
Female patients who are either pregnant or nursing
Enrolled in or planning to enroll in Cognitive-Behavioral Therapy.
Patient judged unlikely to be able to tolerated a medication washout.
Medical conditions that make participation unsafe (e.g., high blood pressure, head injury)
Currently on medications that make participation unsafe
History of allergy, sensitivity, or intolerance to N-methyl-D-aspartate receptor (NMDAR) ligands including ketamine, dextromethorphan, memantine, methadone, dextropropoxyphene, or ketobemidone.
Clareo Health | Open Label Trial of Rapastinel (Formerly GLYX-13) in Individuals With Obsessive-Compulsive Disorder
